Can the U.S. pharmaceutical supply chain come home — or, at least, get closer to it?

Is it time to write the obituary for the era of free trade? Proponents of the practice have had a rough time of it lately.

Shippers are holding their collective breath to see how a rash of uncertainties surrounding the U.S. and global economies will impact freight rates in 2025.

Ashley Craig, chair of the International Trade and Logistics group of Venable LLP, reviews key aspects of the second Trump administration’s trade policy, including tariffs, sanctions and forced-labor bans.

Think violations of environmental standards and human rights in supply chains are limited to places far from U.S. shores? Think again.

In supply chain, all the talk today is about AI-driven autonomous operations, removing the need for human intervention in key decision-making.

Of all the many links that make up a global supply chain, drayage is among the most challenging to perform efficiently and profitably.

Jess Dankert, VP supply chain with the Retail Industry Leaders Association, offers an advance look at LINK 2025, RILA's annual retail supply chain conference, February 16-19 in Orlando, Florida.

How is one of the world’s largest pharmaceutical companies promoting sustainability and regulatory compliance throughout its extensive supply chain?

Can Mexico keep attracting manufacturers in a time of political and economic uncertainty?